Who owns CADL?
Institutional ownership of Candel Therapeutics Inc. from Form 13F, Q2 2026
138 institutional managers reported holding Candel Therapeutics Inc. (CADL) in Form 13F filings for Q2 2026, with 50,394,372 shares worth $519M. The largest reported holder was FMR LLC. Managers that filed both quarters added a net 7,137,507 shares (+16.5%). 40 opened new positions and 13 sold out.
- Funds holding
- 138
- Value held
- $519M
- New / sold out
- 40 / 13
- Net shares, same filers
- +16.5%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of CADL
Share of 13F holdings is each fund's shares as a share of the 50,394,372 CADL shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- State Street Corp Added+$28.1M
- BlackRock, Inc. Added+$19.2M
- Portolan Capital Management, LLC Added+$6.1M
- Geode Capital Management, LLC Added+$5.5M
- Saturn V Capital Management LP Added+$4.2M
- Kennedy Capital Management LLC Added+$4.1M
- Marshall Wace, LLP New+$3.1M
- Bank of America Corp Added+$2.4M
- Vanguard Capital Management LLC Added+$2.4M
- Wellington Management Group LLP New+$2.1M
Biggest sellers in Q2 2026
- Vestal Point Capital, LP Sold out-$5.5M
- Heights Capital Management, Inc Sold out-$3.8M
- Halter Ferguson Financial Inc. Trimmed-$1.4M
- ExodusPoint Capital Management, LP Sold out-$1.1M
- Kynam Capital Management, LP Trimmed-$1.1M
- Ghisallo Capital Management LLC Trimmed-$1.0M
- Woodline Partners LP Sold out-$768K
- Two Sigma Investments, LP Trimmed-$626K
- Stonepine Capital Management, LLC Sold out-$502K
- Bridgeway Capital Management, LLC Sold out-$368K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $106M and sold $18.3M; 62 added and 23 trimmed.
Schedule 13D and 13G filings on CADL
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-07-27BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2026-05-15RTW INVESTMENTS, LP SCHEDULE 13G filed by Candel Therapeutics Inc.Schedule 13G
- 2026-01-21BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2025-06-30ACORN BIOVENTURES, L.P. SCHEDULE 13G filed by Candel Therapeutics Inc.Schedule 13G
- 2025-02-14BAKER BROS. ADVISORS LP SCHEDULE 13G filed by Candel Therapeutics Inc.Schedule 13G
- 2025-02-07FMR LLC SCHEDULE 13G filed by Candel Therapeutics Inc.Schedule 13G
Questions about CADL ownership
- Who owns CADL stock?
- 138 institutional investment managers reported CADL positions in their Form 13F filings for Q2 2026, holding 50,394,372 shares worth $519M in total. FMR LLC reported the largest position.
- Are funds buying or selling CADL?
- In Q2 2026, 40 managers opened new CADL positions, 62 added, 23 trimmed and 13 sold out. Managers that filed in both quarters added a net 7,137,507 shares.
- How current is this CADL institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to CADL by CUSIP. Options are left out. CADL news and filings · CADL insider trades · Top funds